Thermo Fisher Scientific | TMO - Selling And Administration Expenses


Thermo Fisher Scientific reported $1.8B in Selling and Administration Expenses for its fiscal quarter ending in March of 2026.





Selling And Administration Expenses Change Date
Abbott USD 3.27B 138M Mar/2026
Agilent USD 465M 11M Mar/2026
Becton, Dickinson and Co. USD 1.21B 180M Mar/2026
Bio Techne USD 109.34M 4.35M Mar/2026
Bio-Rad Laboratories USD 221M 14.2M Dec/2025
Boston Scientific USD 1.78B 53M Mar/2026
Bruker USD 242.1M 5.1M Mar/2026
Charles River Laboratories USD 159.42M 36.71M Mar/2026
Danaher USD 1.86B 166M Mar/2026
Dentsply International USD 351M 32M Mar/2026
Edwards Lifesciences USD 522.2M 80.7M Mar/2026
General Electric Aerospace USD 1.08B 496M Mar/2026
Henry Schein USD 809M 1000K Mar/2026
Illumina USD 272M 11M Mar/2026
Intuitive Surgical USD 613.3M 73.8M Mar/2026
IQVIA Holdings USD 502M 34M Mar/2026
Laboratory Of America USD 551M 12.4M Mar/2026
Medtronic 2.96B 9M Dec/2025
Mettler Toledo International USD 258.33M 1.5M Mar/2026
Myriad Genetics USD 122.3M 6.7M Dec/2025
Olympus JPY 139.34B 13.69B Mar/2026
OraSure Technologies USD 13.21M 3.29M Dec/2025
Quest Diagnostics USD 504M 0 Mar/2026
Repligen USD 76.54M 2.17M Mar/2026
Revvity USD 253.88M 2.15M Mar/2026
Stryker USD 2.15B 17M Mar/2026
Thermo Fisher Scientific USD 1.8B 179M Mar/2026
Veracyte USD 50.84M 7.53M Mar/2026
Waters USD 394M 153.99M Mar/2026
Zimmer Biomet Holdings USD 849.9M 5.8M Mar/2026